You are leaving this website. By clicking ACCEPT, you will be re-directed to a third-party website. Cosette Pharmaceuticals assumes no responsibility for the content of the website(s). Once You click ACCEPT and leave our Website, the Terms of Use and Privacy Policy will immediately cease to apply to any subsequent activity on the other website. Cosette Pharmaceuticals assumes no liability for any damages or injuries of any kind arising third party website(s). Click ACCEPT if you wish to proceed.

logo
Newsroom Careers Contact Us
  • COMPANY
  • PEOPLE
  • PRODUCTS
    • Brands
    • Generic
    • OTC
  • COSETTE CDMO
  • COSETTE CARES
  • PARTNERSHIPS

Now Available From Cosette Pharmaceuticals: Azor, Benicar, Benicar HCT, Effient, Evoxac, Tribenzor and Welchol

October 10, 2022

BRIDGEWATER, NJ – OCTOBER 10, 2022:

RECENT POSTS

Cosette Pharmaceuticals Announces Acquisition of Mayne Pharma, Transforming Company into a Leader in Women’s Health and Dermatology

February 21, 2025

Cosette Pharmaceuticals Appoints Vincent Colicchio as Senior Vice President of Operations

February 25, 2025

Cosette Pharmaceuticals Appoints Brad Leonard as Vice President, Commercial Operations

February 3, 2025

Avista Capital Partners and Hamilton Lane Announce Partnership in Cosette Pharmaceuticals

July 17, 2024

Cosette Pharmaceuticals Acquires Ambien® and Ambien CR® (Zolpidem Tartrate) Tabs from Sanofi US in the US Market

July 10, 2024

Innovating every day.™

Please sign up to our news alerts. Once you’ve submitted your request, you will receive your activation link by email.

    Sign up for Press Releases



    ©2025 Cosette Pharmaceuticals

    Our CompanyOur PeopleOur ProductsPartnershipsCareersNewsroomContact UsTerms of UsePrivacy Policy

    Cosette Pharma
    • Home
    • Our Company
    • Our People
    • Products
      • — Brands —
      • — Generic —
      • — OTC —
    • Partnerships
    • Careers
    • Newsroom
    • Contact Us
    • Terms Of Use
    • Privacy Policy

    Privacy Preference Center

    Privacy Preferences

    Cosette Pharmaceuticals has received reports of employment scams in recent months that often seek financial and personally identifiable information from job candidates. Unsuspecting job seekers have reported receiving unsolicited contacts from individuals purporting to be or represent Cosette employees. This usually leads to “online interviews” conducted via teleconference applications for virtual positions within the company that do not actually exist. Please be advised that Cosette does not extend unsolicited employment offers and does not utilize chat rooms or ask for financial information during the interview process.

    If you would like to pursue employment opportunities with Cosette, please visit our official career website at: www.cosettepharma.com

    • You may report any potential scams to [email protected].
    • You should also report the activity to the Internet Crime Complaint Center at ic3.gov, FTC Fraud Center at www.reportfraud.ftc.gov or your local FBI field office.
    • If you reveal your financial information, contact your financial institution immediately and direct them to stop or reverse the transactions.
    • Ask your financial institution to contact the corresponding financial institution where the fraudulent or suspicious transfer was sent.